A pH-Responsive Ti-Based Local Drug Delivery System for Osteosarcoma Therapy
Source abstract
Abstract
Osteosarcoma is one of the major bone cancers, especially for youngsters. The current treatment usually requires systemic chemotherapy and the removal of bone tumors. Titanium (Ti)-based implants can be modified as local drug delivery (LDD) systems for controllable and localized chemotherapeutic drug release. In this work, a pH-responsive Ti-based LDD prototype was designed by introducing polydopamine (PDA) to release doxorubicin (DOX) around osteosarcoma cells with low pH. Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), and a contact angle meter were applied for surface characterization. Both direct and indirect cell culture modes were performed for biocompatibility and biofunction assessments. The results indicate that the Ti-based LDD prototype exhibits significant pH-dependent DOX release. The cumulative release can reach up to approximately 40% at pH = 6.0 after 72 h, but only around 20% at pH = 7.4. The Ti-based LDD implant shows good biocompatibility with approximately 93% viability of MC3T3 cells after direct culture in vitro for 24 h. Both direct and indirect culture modes verify the good anti-osteosarcoma function of the LDD implant, which should be attributed to the pH-responsive release of DOX.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Polymer Surface Interaction Studies · Metal and Thin Film Mechanics · Dendrimers and Hyperbranched Polymers
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
College of Biology, Hunan University, Changsha 410082, China
State Key Laboratory of Powder Metallurgy, Central South University, Changsha 410083, China
Funding
National Natural Science Foundation of China · Key Research and Development Program of Hunan Province in China · Excellent Youth Project of Hunan Province in China
References (56)
Show source-provided references
1. Bone: Conventional osteosarcoma
2. Lin, P.P., and Patel, S. (2013). Osteosarcoma. Bone Sarcoma, Springer.10.1007/978-1-4614-5194-5 ↗
3. Chemotherapy and the war on cancer10.1038/nrc1529 ↗
4. Principles of nanoparticle design for overcoming biological barriers to drug delivery10.1038/nbt.3330 ↗
5. Recurrent Osteosarcoma Presenting as an Isolated Bone Marrow Relapse10.1097/MPH.0000000000000719 ↗
6. Bone biomaterials and interactions with stem cells10.1038/boneres.2017.59 ↗
7. Local drug delivery systems for inflammatory diseases: Status quo, challenges, and opportunities10.1016/j.jconrel.2020.12.025 ↗
8. Takahashi, M., Sato, K., Togawa, G., and Takada, Y. (2022). Mechanical Properties of Ti-Nb-Cu Alloys for Dental Machining Applications. J. Funct. Biomater., 13.10.3390/jfb13040263 ↗
9. Sass, J.-O., Sellin, M.-L., Kauertz, E., Johannsen, J., Weinmann, M., Stenzel, M., Frank, M., Vogel, D., Bader, R., and Jonitz-Heincke, A. (2024). Advanced Ti–Nb–Ta Alloys for Bone Implants with Improved Functionality. J. Funct. Biomater., 15.10.3390/jfb15020046 ↗
10. Surface modification techniques of titanium and titanium alloys for biomedical orthopaedics applications: A review10.1016/j.colsurfb.2023.113339 ↗
11. Vishnu, J., Kesavan, P., Shankar, B., Dembińska, K., Swiontek Brzezinska, M., and Kaczmarek-Szczepańska, B. (2023). Engineering Antioxidant Surfaces for Titanium-Based Metallic Biomaterials. J. Funct. Biomater., 14.10.3390/jfb14070344 ↗
12. Meng, F., Yin, Z., Ren, X., Geng, Z., and Su, J. (2022). Construction of Local Drug Delivery System on Titanium-Based Implants to Improve Osseointegration. Pharmaceutics, 14.10.3390/pharmaceutics14051069 ↗
13. Ma, X., Gao, Y., Zhao, D., Zhang, W., Zhao, W., Wu, M., Cui, Y., Li, Q., Zhang, Z., and Ma, C. (2022). Titanium Implants and Local Drug Delivery Systems Become Mutual Promoters in Orthopedic Clinics. Nanomaterials, 12.10.3390/nano12010047 ↗
14. Controlled and localized drug delivery using Titania nanotubes10.1016/j.mtcomm.2022.103843 ↗
15. Titanium dioxide nanotubes as drug carriers for infection control and osteogenesis of bone implants10.1007/s13346-021-00980-z ↗
16. Macro-micron-nano-featured surface topography of Ti-6Al-4V alloy for biomedical applications10.1007/s12598-018-1150-7 ↗
17. Early Antimicrobial Evaluation of Nanostructured Surfaces Based on Bacterial Biological Properties10.1021/acsbiomaterials.2c00559 ↗
18. Influence of heterogeneous microstructures on anodization behavior and biocompatibility of Ti−15Zr alloy10.1016/S1003-6326(23)66245-4 ↗
19. Titanium wire implants with nanotube arrays: A study model for localized cancer treatment10.1016/j.biomaterials.2016.05.048 ↗
20. Exosome-integrated titanium oxide nanotubes for targeted bone regeneration10.1016/j.actbio.2019.01.006 ↗
21. Applications of Polydopamine in Implant Surface Modification10.1002/mabi.202300067 ↗
22. Polydopamine Surface Chemistry: A Decade of Discovery10.1021/acsami.7b19865 ↗
23. pH-Sensitive Polydopamine Nanocapsules for Cell Imaging and Drug Delivery Based on Folate Receptor Targeting10.1166/jbn.2013.1611 ↗
24. Polydopamine Modified TiO2 Nanotube Arrays for Long-Term Controlled Elution of Bivalirudin and Improved Hemocompatibility10.1021/acsami.7b06108 ↗
25. Polydopamine and hyaluronic acid immobilisation on vancomycin-loaded titanium nanotube for prophylaxis of implant infections10.1016/j.colsurfb.2022.112582 ↗
26. Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein10.1016/j.phrs.2021.105975 ↗
27. TiO2 nanotubes, nanochannels and mesosponge: Self-organized formation and applications10.1016/j.nantod.2013.04.010 ↗
28. Engineering of Micro- to Nanostructured 3D-Printed Drug-Releasing Titanium Implants for Enhanced Osseointegration and Localized Delivery of Anticancer Drugs10.1021/acsami.7b09916 ↗
29. Exploring doxorubicin localization in eluting TiO2 nanotube arrays through fluorescence correlation spectroscopy analysis10.1039/c2an36052g ↗
30. Dynamics of three-dimensional replication patterns during the s-phase, analysed by double labelling of dna and confocal microscopy10.1242/jcs.103.3.857 ↗
31. A guided tour into subcellular colocalization analysis in light microscopy10.1111/j.1365-2818.2006.01706.x ↗
32. Covalent attachment of a bioactive hyperbranched polymeric layer to titanium surface for the biomimetic growth of calcium phosphates10.1007/s10856-010-4181-7 ↗
33. In situ ATR-FTIR and UV-Visible spectroscopy study of photocatalytic oxidation of ethanol over TiO2 nanotubes10.1080/00032719.2010.507296 ↗
34. Mussel-inspired polydopamine coating as a versatile platform for synthesizing polystyrene/Ag nanocomposite particles with enhanced antibacterial activities10.1039/C4TB00460D ↗
35. Biosilica/polydopamine/silver nanoparticles composites: New hybrid multifunctional heterostructures obtained by chemical modification of Thalassiosira weissflogii silica shells10.1557/mrc.2018.103 ↗
36. Doxorubicin-loaded pH-responsive chitin nanogels for drug delivery to cancer cells10.1016/j.carbpol.2011.10.040 ↗
37. Synthesis, characterization and surface modification of PES hollow fiber membrane support with polydopamine and thin film composite for energy generation10.1016/j.cej.2013.12.094 ↗
38. Different antibacterial mechanisms of titania nanotube arrays at various growth phases of E. coli10.1016/S1003-6326(21)65767-9 ↗
39. Nanoporous anodic titanium dioxide layers as potential drug delivery systems: Drug release kinetics and mechanism10.1016/j.colsurfb.2016.03.073 ↗
40. Mathematical models in drug delivery: How modeling has shaped the way we design new drug delivery systems10.1016/j.jconrel.2014.06.041 ↗
41. Modeling and comparison of release profiles: Effect of the dissolution method10.1016/j.ejps.2017.06.021 ↗
42. Interpreting non-linear drug diffusion data: Utilizing Korsmeyer-Peppas model to study drug release from liposomes10.1016/j.ejps.2019.105026 ↗
43. Release Kinetics—Concepts and applications
44. Advancing the field of drug delivery: Taking aim at cancer10.1016/S1535-6108(03)00276-9 ↗
45. A pH-Responsive Nanoplatform Based on Magnetic Mesoporous Silica Nanoparticles for Enhanced Treatment of Pancreatic Cancer10.1021/acsanm.3c04596 ↗
46. Amphiphilic TiO2 Nanotube Arrays: An Actively Controllable Drug Delivery System10.1021/ja810130h ↗
47. Enhanced adhesion of PEDOT: PSS to substrates using polydopamine as a primer10.1038/s41428-023-00846-w ↗
48. A Micelle Self-Assembled from Doxorubicin-Arabinoxylan Conjugates with pH-Cleavable Bond for Synergistic Antitumor Therapy10.1186/s11671-017-1836-z ↗
49. Doxorubicin drug release behavior from amino-silanated graphene oxide nanocarrier10.1016/j.diamond.2022.109569 ↗
50. Tang, H., Zhao, W., Yu, J., Li, Y., and Zhao, C. (2019). Recent Development of pH-Responsive Polymers for Cancer Nanomedicine. Molecules, 24.10.3390/molecules24010004 ↗
51. Mussel-inspired polydopamine coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release10.1016/j.ijpharm.2013.12.045 ↗
52. Acidity/hydrogen peroxide-responsive PEGylated chitosan-modified polydopamine nanoparticles to realize effective photothermal conversion and intracellular drug delivery10.1016/j.eurpolymj.2023.112365 ↗
53. Improving biocompatibility for next generation of metallic implants10.1016/j.pmatsci.2022.101053 ↗
54. A pH-sensitive carbonic anhydrase Ⅸ-targeted near-infrared probe for fluorescent sensing and imaging of hypoxic osteosarcoma10.1016/j.snb.2022.133171 ↗
55. Carbonic anhydrase IX and acid transport in cancer10.1038/s41416-019-0642-z ↗
56. Understanding metabolic alterations and heterogeneity in cancer progression through validated immunodetection of key molecular components: A case of carbonic anhydrase IX10.1007/s10555-021-10011-5 ↗